The Centers for Medicare & Medicaid Services (CMS) on June 12, 2026, released its first proposed rule to implement the Inflation Reduction Act (IRA) Medicare Drug Price Negotiation Program through formal notice-and-comment rulemaking. The proposal represents a significant milestone in the evolution of the program, which has operated under guidance documents since its launch and now must transition to codification through regulation, beginning with Initial Price Applicability Year (IPAY) 2029….
By: Holland & Knight LLP
By: Holland & Knight LLP
